Elsevier logo

Publisher: Elsevier

Volume 9, Number 2, February 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Promises and pitfalls of anti-angiogenic therapy in clinical trials
pp. 53-58(6)
Authors: McCarty M.F.; Liu W.; Fan F.; Parikh A.; Reimuth N.; Stoeltzing O.; Ellis L.M.

Genetic modifiers of cardiac arrhythmias
pp. 59-66(8)
Authors: Cheng C.-F.; Kuo H.-C.; Chien K.R.

Non-viral and hybrid vectors in human gene therapy: an update
pp. 67-72(6)
Authors: Schmidt-Wolf G.D.; Schmidt-Wolf I.G.H.

Cyclooxygenase-2: a therapeutic target in angiogenesis
pp. 73-78(6)
Authors: Iniguez M.A.; Rodrguez A.; Volpert O.V.; Fresno M.; Redondo J.M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A